Filing Details
- Accession Number:
- 0001171843-21-002445
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-13 11:29:59
- Reporting Period:
- 2021-04-12
- Accepted Time:
- 2021-04-13 11:29:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1684144 | Zomedica Corp. | ZOM | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1821115 | Marie Ann Cotter | C/O Zomedica Corp. 100 Phoenix Drive, Suite 125 Ann Arbor MI 48018 | Cfo And Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Without Par Value | Acquisiton | 2021-04-12 | 33,332 | $0.19 | 33,332 | No | 4 | M | Direct | |
Common Stock, Without Par Value | Disposition | 2021-04-12 | 33,332 | $1.16 | 0 | No | 4 | S | Direct | |
Common Stock, Without Par Value | Acquisiton | 2021-04-12 | 25,000 | $0.11 | 25,000 | No | 4 | M | Direct | |
Common Stock, Without Par Value | Disposition | 2021-04-12 | 25,000 | $1.16 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock, Without Par Value | Stock option (right to buy) | Disposition | 2021-04-12 | 33,332 | $0.00 | 33,332 | $0.19 |
Common Stock, Without Par Value | Stock option (right to buy) | Disposition | 2021-04-12 | 25,000 | $0.00 | 25,000 | $0.11 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
166,668 | 2025-03-14 | No | 4 | M | Direct | |
275,000 | 2025-10-01 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17, 2021.
- The option vest as to 25% on March 14, 2020, with 25% to vest annually thereafter.
- The option vests in 4 equal annual installments commencing October 1, 2020.